Missouri, Kansas and Idaho can press forward with their lawsuit to restrict access to the abortion drug mifepristone, a federal judge ruled Thursday, months after the US Supreme Court had rejected an earlier version of the legal challenge.

U.S. District Judge Matthew Kacsmaryk is ripping up legal procedure, the better to keep a high-profile abortion case in his hands as the new administration takes over. Last June, the Supreme Court found that the anti-abortion doctors aiming to make abortion drug mifepristone less accessible lacked standing,

The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public health risk.

An incoming new president and state legislative sessions ramping up are likely to bring more changes to abortion policy across the U.S., which is still settling after the seismic shift in 2022 when the U.

A Texas judge has allowed Idaho, Kansas, and Missouri to challenge federal rules on the abortion drug mifepristone. The states want stricter regulations, citing conflict with state abortion laws. The case continues despite a prior Supreme Court decision maintaining access to the drug.

After abortion opponents and doctors failed in their case to have the drug restricted — the Supreme Court ruled they lacked standing — Idaho, Kansas, and Missouri stepped in. Meanwhile, other states are making moves to protect reproductive rights.

Idaho, Kansas and Missouri can pursue legal action to prohibit the Food and Drug Administration from allowing online prescriptions.

A federal judge in Texas is allowing Idaho, Kansas and Missouri to pursue a challenge seeking to restrict access to the abortion pill Mifepristone nationwide.

A Texas federal judge Thursday ruled Idaho, Kansas, and Missouri can join a case challenging access to the abortion pill. Trump-appointed Judge Matthew Kacsmaryk allowed the states to pursue legal action in Texas that seeks to prohibit the Food and Drug Administration (FDA) from allowing online prescriptions for Mifepristone over concerns that it could “undermine state abortion laws and frustrate state law enforcement,

The Trump-appointed federal judge who unilaterally ordered the FDA to revoke approval of an abortion drug allowed Idaho, Kansas and Missouri to move forward in another lawsuit over mifepristone.

Sen. Cory Booker asks Pam Bondi if the Justice Department, under her leadership, would defend access to medication abortion. "I have always been pro-life, but I will look at that policy," Bondi says. "I will not not let my personal beliefs affect how I carry out the law." pic.twitter.com/7FJfIlo5Cz